Autopsy report · NCT05129423

A Study of MTPS9579A in Participants With Refractory Chronic Spontaneous Urticaria

“Development of MTPS9579A was terminated for strategic/business reasons.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Genentech, Inc.

Sponsor type

Industry

Conditions

Chronic Spontaneous Urticaria

Interventions

MTPS9579A; Placebo

Participants

0

Trials that died the same way

• KSD-201 Treatment for Advanced Clear Cell Renal Cell Carcinoma: an Early Exploratory Clinical Study
  “Due to a strategic adjustment, the company has decided to terminate the project.” (56% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.